[go: up one dir, main page]

WO2009135634A1 - Dispositif et procédé destinés à agir sur des virus de l'herpès et/ou sur les substances pouvant pénétrer dans la peau d'êtres vivants lors de la piqûre par un insecte ou similaires - Google Patents

Dispositif et procédé destinés à agir sur des virus de l'herpès et/ou sur les substances pouvant pénétrer dans la peau d'êtres vivants lors de la piqûre par un insecte ou similaires Download PDF

Info

Publication number
WO2009135634A1
WO2009135634A1 PCT/EP2009/003191 EP2009003191W WO2009135634A1 WO 2009135634 A1 WO2009135634 A1 WO 2009135634A1 EP 2009003191 W EP2009003191 W EP 2009003191W WO 2009135634 A1 WO2009135634 A1 WO 2009135634A1
Authority
WO
WIPO (PCT)
Prior art keywords
substances
skin
herpesviruses
insect
herpes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2009/003191
Other languages
German (de)
English (en)
Inventor
Klaus Büttner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE200810032349 external-priority patent/DE102008032349A1/de
Application filed by Individual filed Critical Individual
Publication of WO2009135634A1 publication Critical patent/WO2009135634A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy

Definitions

  • the invention relates to a device and a method for acting on herpesviruses and / or those substances that can enter the skin of living beings during the insertion of an insect or the like
  • the invention is directed to a device and a method for acting on herpesviruses and / or for inactivating / denaturing inflammatory substances or poisons and includes the non-invasive treatment of herpesviruses and / or insects (mosquitoes, bees, wasps, hornets, etc. ), Arachnids or reptiles imparted foreign substances by a portable ultrasonic source, which achieves the targeted inactivation / denaturation of herpesviruses and / or the transmitted foreign substances by mechanical stress and thus prevents the immune reaction to run off
  • a piece of music transfers impurities that are supposed to fulfill different tasks. These ensure blood flow to the animal by counteracting blood clotting or repelling the alleged adversary with an anesthetic. These foreign substances can cause different reactions in humans.
  • the spectrum of the reaction ranges from harmless ones Symptoms like itching or
  • the foreign bodies are proteins, protein mixtures or substances similar to proteins.
  • Bee venom is a complex mixture of various proteins that can be anti-inflammatory, act as a painkiller and can also be hemostatic. In the case of hornet poison, the pain-enhancing acetylcholine is added.
  • the sting toxins can be proteins, protein mixtures and enzymes.
  • the aim of the present invention is now a method / device that is able to act on herpesviruses and / or on these foreign or toxic substances before they can develop the effects described above on the body or even with anaphylactic shock with acute danger to life can come.
  • the device according to the invention is a portable device and use immediately after a puncture, so even hours after puncture relief can be achieved with the method and apparatus according to the invention, since, as already stated, the invading substances can be specifically treated or degraded at the injection site and the surrounding areas.
  • the aim achieved by the present invention is to prevent the passage of the immune reaction to combat the foreign proteins in the human body by timely inactivation / denaturation of the foreign proteins.
  • the method according to the invention or the device according to the invention uses the mechanical stress on the foreign protein molecules caused by ultrasound (18,000 Hz to 3 MHz). This mechanical stress leads to denaturation of the molecule, so that the molecule is changed in its external form or into smaller components disintegrates This decomposition process changes or destroys the molecule and makes it easier to break down from the body.
  • a frequency of 30 to 50 khz is preferred
  • the device consists of an ultrasound generator, a transducer, a housing and an energy source.
  • an ultrasound gel is recommended

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne un dispositif et un procédé destinés à agir sur des virus de l'herpès et/ou sur les substances pouvant pénétrer dans la peau d'êtres vivants lors de la piqûre par un insecte ou similaires. Le procédé fait intervenir les ultrasons. Le dispositif est caractérisé par un générateur d'ultrasons dont la tête ultrasonore émettant à la fréquence ultrasonore souhaitée peut être amenée à l'endroit de la piqûre.
PCT/EP2009/003191 2008-05-07 2009-05-04 Dispositif et procédé destinés à agir sur des virus de l'herpès et/ou sur les substances pouvant pénétrer dans la peau d'êtres vivants lors de la piqûre par un insecte ou similaires Ceased WO2009135634A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE202008006298.5 2008-05-07
DE202008006298 2008-05-07
DE200810032349 DE102008032349A1 (de) 2008-07-09 2008-07-09 Vorrichtung zum Einwirken auf diejenigen Stoffe, die beim Einstich eines Insekts oder dgl. in die Haut von Lebewesen gelangen können
DE102008032349.7 2008-07-09

Publications (1)

Publication Number Publication Date
WO2009135634A1 true WO2009135634A1 (fr) 2009-11-12

Family

ID=41100557

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/003191 Ceased WO2009135634A1 (fr) 2008-05-07 2009-05-04 Dispositif et procédé destinés à agir sur des virus de l'herpès et/ou sur les substances pouvant pénétrer dans la peau d'êtres vivants lors de la piqûre par un insecte ou similaires

Country Status (1)

Country Link
WO (1) WO2009135634A1 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4646725A (en) * 1983-11-16 1987-03-03 Manoutchehr Moasser Method for treating herpes lesions and other infectious skin conditions
US20070039389A1 (en) * 1998-09-11 2007-02-22 Brooks Juliana H Methods for using resonant acoustic and/or resonant acousto-EM energy to detect and/or effect structures
EP1844750A1 (fr) * 2006-04-12 2007-10-17 Lain Electronic S.r.L. Dispositif pour le traitement de la cellulite et du tissu adipeux
WO2008070580A2 (fr) * 2006-12-04 2008-06-12 Therative, Inc. Dispositifs et procédés de traitement de problèmes cutanés

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4646725A (en) * 1983-11-16 1987-03-03 Manoutchehr Moasser Method for treating herpes lesions and other infectious skin conditions
US20070039389A1 (en) * 1998-09-11 2007-02-22 Brooks Juliana H Methods for using resonant acoustic and/or resonant acousto-EM energy to detect and/or effect structures
EP1844750A1 (fr) * 2006-04-12 2007-10-17 Lain Electronic S.r.L. Dispositif pour le traitement de la cellulite et du tissu adipeux
WO2008070580A2 (fr) * 2006-12-04 2008-06-12 Therative, Inc. Dispositifs et procédés de traitement de problèmes cutanés

Similar Documents

Publication Publication Date Title
DE69709682T2 (de) Gruene salbe
DE2832204A1 (de) Mittel zur behandlung von nervenerkrankungen, verfahren zu seiner herstellung und seine verwendung
EP1244462B1 (fr) Preparation pharmaceutique a base de venin d'araignee, sa preparation et son utilisation pour traiter des affections tumorales
WO2009135634A1 (fr) Dispositif et procédé destinés à agir sur des virus de l'herpès et/ou sur les substances pouvant pénétrer dans la peau d'êtres vivants lors de la piqûre par un insecte ou similaires
WO2005002604A1 (fr) Principe actif pharmaceutique permettant de lutter contre les maladies tumorales
DE102008032349A1 (de) Vorrichtung zum Einwirken auf diejenigen Stoffe, die beim Einstich eines Insekts oder dgl. in die Haut von Lebewesen gelangen können
Sethi et al. Bee sting envenomation: rare fatality
Çetinkaya et al. Evaluation of the protective effect of the cup therapy on the epileptic seizure in rats
STAINBROOK The experimental induction of acute animal behavior disorders as a method in psychosomatic research
DE4002840A1 (de) Verfahren zur bekaempfung stressinduzierter dysregulationen
DE102005038768A1 (de) Pharmazeutischer Wirkstoff gegen Borreliose
WO1990010452A1 (fr) Fraction proteinique de l'appareil de photosynthese vegetal utile comme substance active de dissolution selective de cellules cancereuses et pour le traitement ulterieur de cicatrices, de cheloides et de processus inflammatoires; substances pharmaceutiques contenant cette fraction proteinique
DE10324062A1 (de) Pharmazeutischer Wirkstoff
DE10324861A1 (de) Pharmazeutischer Wirkstoff
Echterhoff Psychologische Unfallnachsorge
WO2006134166A2 (fr) Principe actif pharmaceutique pour franchir la barriere hemato-encephalique en liaison avec un principe actif acquis a partir d'un venin biogene, pour lutter contre des tumeurs au cerveau
EP2371216B1 (fr) Procédé de conservation de tissu adipeux
Swathi et al. Protective effect of alpinia galanga aganist d-galactose induced brain aging
AT54880B (de) Verfahren zur Herstellung von zur lokalen Immunisierung erkranker Gewebsteile dienenden Stoffen.
WO2005103231A2 (fr) Cellules dendritiques chargees de substances toxiques destinees au traitement de carcinomes de cellules hepatiques
WO2005002616A1 (fr) Principe actif pharmaceutique luttant contre les tumeurs et contenant du poison de l'araignee de la famille des loxoscelidae
DE102006052504A1 (de) Verfahren zum Herstellen eines Mittels gegen eine Infektionskrankheit
DE102007041735A1 (de) Aminosäure-Mineral-Peptid-Komplex, insbesondere quanten-mechanisch modifiziert, als Rezeptur zur Regulierung der Haut
Bhat et al. Makshika Visha-The Concepts of Honey Bee Envenomation in Ayurveda
Büchler¹ et al. V. Leber-Galle-Pankreas

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09741853

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09741853

Country of ref document: EP

Kind code of ref document: A1